Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004

Sex Transm Dis. 2007 May;34(5):288-93. doi: 10.1097/01.olq.0000237838.43716.ee.

Abstract

Objective: The objective of this study was to evaluate trends in HIV postexposure prophylaxis (PEP) requests after sexual exposure, compliance, and outcome of follow-up HIV tests.

Study design: The authors conducted a retrospective analysis of all HIV PEP requests after sexual exposure between January 1, 2000, and December 31, 2004, in Amsterdam.

Results: In 5 years, there was a very modest increase in PEP requests, of which most (75%) came from men who have sex with men (MSM). Although 70% reported side effects, 85% completed their PEP course. Sexual assault victims less often completed their course (odds ratio [OR] = 0.1; 95% confidence interval [CI] = 0.05-0.4, P = 0.001). People who used HIV PEP more often complied with follow-up tests than people who did not use PEP (OR = 3.5; 95% CI = 1.6-7.9, P = 0.002). One HIV seroconversion was found caused by a later exposure than that for which PEP was given.

Conclusions: Despite a widely available PEP program in Amsterdam, the number of PEP requests remained low. Most people completed their PEP course; compliance with follow-up HIV testing was high.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-HIV Agents / administration & dosage*
  • Chemoprevention
  • Child
  • Crime Victims
  • Delivery of Health Care
  • Disease Transmission, Infectious / prevention & control*
  • Drug Administration Schedule
  • Female
  • HIV Infections / epidemiology*
  • HIV Infections / etiology
  • HIV Infections / pathology
  • HIV Infections / prevention & control*
  • HIV Infections / transmission
  • Humans
  • Medical Records
  • Middle Aged
  • Netherlands / epidemiology
  • Patient Acceptance of Health Care / statistics & numerical data*
  • Patient Compliance / statistics & numerical data*
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Retrospective Studies
  • Sexual Behavior

Substances

  • Anti-HIV Agents